Vascular mimicry in glioblastoma following anti-angiogenic and anti-20-HETE therapies
Kartik Angara , Mohammad H Rashid , Adarsh Shankar , Roxan Ara
Histology and Histopathology 32 ( 9) 917 -928
23
2017
Role of GSTM3 Polymorphism in the Risk of Developing Esophageal Cancer
Meenu Jain , Shaleen Kumar , Punita Lal , Anu Tiwari
Cancer Epidemiology, Biomarkers & Prevention 16 ( 1) 178 -181
38
2007
Haplotypes of microsomal epoxide hydrolase and x-ray cross-complementing group 1 genes in Indian hepatocellular carcinoma patients.
Manjula Kiran , Yogesh K. Chawla , Meenu Jain , Jyotdeep Kaur
DNA and Cell Biology 28 ( 11) 573 -577
18
2009
Intravenous Formulation of HET0016 Decreased Human Glioblastoma Growth and Implicated Survival Benefit in Rat Xenograft Models.
Meenu Jain , Nipuni-Dhanesha H Gamage , Meshal Alsulami , Adarsh Shankar
Scientific Reports 7 ( 1) 41809
19
2017
ZNF367 Inhibits Cancer Progression and Is Targeted by miR-195
Meenu Jain , Lisa Zhang , Myriem Boufraqech , Yi Liu-Chittenden
PLOS ONE 9 ( 7)
27
2014
Combination of vatalanib and a 20-HETE synthesis inhibitor results in decreased tumor growth in an animal model of human glioma
Ali Syed Arbab , Adarsh Shankar , Thaiz Borin , Asm Iskander
OncoTargets and Therapy 9 1205 -1219
11
2016
Microsomal epoxide hydrolase (EPHX1), slow (exon 3, 113His) and fast (exon 4, 139Arg) alleles confer susceptibility to squamous cell esophageal cancer.
Meenu Jain , Anup Raj Tilak , Rohit Upadhyay , Ashwani Kumar
Toxicology and Applied Pharmacology 230 ( 2) 247 -251
31
2008
MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors
Dhaval Patel , Myriem Boufraqech , Meenu Jain , Lisa Zhang
Surgery 154 ( 6) 1224 -1229
64
2013
Abstract B30: MicoRNA mediated regulation of antiangiogenic resistance in glioblastoma
Meenu Jain , Bhagelu Achyut , Adarsh Shankar , Kartik Angara
Cancer Research 75
2015
Association of TNFA (-308G>A) and IL-10 (-819C>T) promoter polymorphisms with risk of cervical cancer.
HariOm Singh , Meenu Jain , Rekha Sachan , Balraj Mittal
International Journal of Gynecological Cancer 19 ( 7) 1190 -1194
34
2009
Association of genetic polymorphisms of N-acetyltransferase 2 and susceptibility to esophageal cancer in north Indian population.
Meenu Jain , Shaleen Kumar , Puneeta Lal , Anu Tiwari
Cancer Investigation 25 ( 5) 340 -346
18
2007
CYP1A1 Msp1 T/C Polymorphism in Esophageal Cancer: No Association and Risk Modulation
Meenu Jain , Shaleen Kumar , Uday C. Ghoshal , Balraj Mittal
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 16 ( 9) 437 -443
10
2007
Integrated genome-wide analysis of genomic changes and gene regulation in human adrenocortical tissue samples.
Sudheer Kumar Gara , Yonghong Wang , Dhaval Patel , Yi Liu-Chittenden
Nucleic Acids Research 43 ( 19) 9327 -9339
19
2015
miR-145 suppresses thyroid cancer growth and metastasis and targets AKT3
Myriem Boufraqech , Lisa Zhang , Meenu Jain , Dhaval Patel
Endocrine-related Cancer 21 ( 4) 517 -531
66
2014
Potential influence of interleukin-1 haplotype IL-1β-511*T-IL-1RN*1 in conferring low risk to middle third location of esophageal cancer: A case–control study
Rohit Upadhyay , Meenu Jain , Shaleen Kumar , Uday C. Ghoshal
Human Immunology 69 ( 3) 179 -186
17
2008
Altered PTEN, CHGA, CHGB and ATRX expression are associated with aggressive Von Hippel- Lindau-associated pancreatic neuroendocrine tumors
Allison B. Weisbrod , Lisa Zhang , Meenu Jain , Stephanie Barak
Journal of The American College of Surgeons 215 ( 3)
2012
Association of ECRG2 TCA short tandem repeat polymorphism with the risk of oesophageal cancer in a North Indian population
Meenu Jain , Shaleen Kumar , Uday C. Ghoshal , Balraj Mittal
Clinical and Experimental Medicine 8 ( 2) 73 -78
3
2008
MMP-7 (−181A>G) promoter polymorphisms and risk for cervical cancer
HariOm Singh , Meenu Jain , Balraj Mittal
Gynecologic Oncology 110 ( 1) 71 -75
33
2008
Altered PTEN, ATRX, CHGA, CHGB, and TP53 expression are associated with aggressive VHL-associated pancreatic neuroendocrine tumors.
Allison B. Weisbrod , Lisa Zhang , Meenu Jain , Stephanie Barak
Hormones and Cancer 4 ( 3) 165 -175
31
2013
p53 Mutation: Critical Mediator of Therapy Resistance against Tumor Microenvironment.
Ali S Arbab , Meenu Jain , BR Achyut ,
Biochemistry & Physiology: Open Access 5 ( 3) 1 -3
4
2016